Last reviewed · How we verify
NCT06928870: NIRS
The Effect of Controlled Hypotension
NA trial testing MAP 55-65 mmHg in Cerebral Hypoperfusion in 60 participants. Not yet recruiting.
1 June 2025
Quick facts
| Lead sponsor | Ankara Etlik City Hospital |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | other |
| Enrollment | 60 |
| Start date | 30 April 2025 |
| Primary completion | 1 June 2025 |
| Estimated completion | 30 June 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- MAP 55-65 mmHg
- MAP 66-75 mmHg
Conditions studied
- Cerebral Hypoperfusion — all drugs for Cerebral Hypoperfusion →
- Hypotension — all drugs for Hypotension →
Sponsor
Ankara Etlik City Hospital
Who can join
Adults 18 to 65, any sex, with Cerebral Hypoperfusion or Hypotension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Controlled hypotension is currently used in spinal surgery to reduce bleeding at the surgical site, improve the surgeon's visibility, and decrease intraoperative blood loss. Although controlled hypotension is considered a beneficial method from a surgical perspective, it is important to be cautious about its side effects. One such side effect is cerebral perfusion insufficiency, which can be managed by monitoring cerebral circulation through regional cerebral oxygen saturation (rSO2). The aim of this study is to compare the effects of controlled hypotension at specific MAP ranges on cerebral oxygen saturation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06928870
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cerebral Hypoperfusion
Currently open trials in the same condition.
- NCT07150260 — Correlation Between Carotid Stump Pressure and Interhemispheric rSO₂ Asymmetry During Awake Carotid Endarterectomy · recruiting
Other Ankara Etlik City Hospital trials
Trials by the same sponsor.
- NCT07472452 — MULTIMODAL APPROACH IN THE DIAGNOSIS OF SEPTIC AKI · not yet recruiting
- NCT07488442 — Efficacy of Cognitive Behavioral Therapy Administered in Patients With Dyssynergic Defecation · NA · recruiting
- NCT07488455 — Effectiveness of Video-Based or Written Pelvic Floor Education in Postpartum Women · NA · recruiting
- NCT07375173 — ORI-Guided FiO₂ Titration in Prone Spine Surgery: Impact on Postoperative Atelectasis Assessed by Lung Ultrasound · NA · not yet recruiting
- NCT07456202 — Menstrual Status, Anesthetic Consumption, and PONV · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06928870 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ankara Etlik City Hospital
- Last refreshed: 15 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06928870.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing